Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Top Cited Papers
Open Access
- 1 September 2008
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 74 (6) , 791-798
- https://doi.org/10.1038/ki.2008.295
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney diseaseKidney International, 2008
- Erythropoietin/erythropoietin‐receptor system is involved in angiogenesis in human hepatocellular carcinomaHistopathology, 2007
- Expression of Erythropoietin and Erythropoietin Receptor in Cervical Cancer and Relationship to Survival, Hypoxia, and ApoptosisClinical Cancer Research, 2006
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and AnemiaNew England Journal of Medicine, 2006
- Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis PatientsJournal of the American Society of Nephrology, 2006
- Editorials: Recombinant Human Erythropoietin: Has Treatment Reached its Full Potential?Seminars in Dialysis, 2006
- Epoetin requirements predict mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 2004
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000American Journal of Kidney Diseases, 2001
- Exercise in Hemodialysis Patients after Treatment with Recombinant Human ErythropoietinNephron, 1991